Evolent Health, Inc. (FRA:9EH)
2.700
+0.020 (0.75%)
Last updated: Jan 30, 2026, 8:12 AM CET
Evolent Health Revenue
Evolent Health had revenue of $479.53M USD in the quarter ending September 30, 2025, a decrease of -22.83%. This brings the company's revenue in the last twelve months to $2.05B, down -16.65% year-over-year. In the year 2024, Evolent Health had annual revenue of $2.55B with 30.09% growth.
Revenue (ttm)
$2.05B
Revenue Growth
-16.65%
P/S Ratio
0.17
Revenue / Employee
$456.46K
Employees
4,500
Market Cap
301.53M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.55B | 590.85M | 30.09% |
| Dec 31, 2023 | 1.96B | 611.88M | 45.26% |
| Dec 31, 2022 | 1.35B | 444.06M | 48.91% |
| Dec 31, 2021 | 907.96M | -16.68M | -1.80% |
| Dec 31, 2020 | 924.64M | 237.52M | 34.57% |
| Dec 31, 2019 | 687.12M | 60.06M | 9.58% |
| Dec 31, 2018 | 627.06M | 192.11M | 44.17% |
| Dec 31, 2017 | 434.95M | 180.76M | 71.11% |
| Dec 31, 2016 | 254.19M | 157.31M | 162.38% |
| Dec 31, 2015 | 96.88M | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | 25.67M | 17.33M | 207.58% |
| Dec 31, 2012 | 8.35M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Allane SE | 827.69M |
| SIMONA Aktiengesellschaft | 586.42M |
| centrotherm international AG | 288.81M |
| Eleving Group | 203.19M |
| ÜSTRA Hannoversche Verkehrsbetriebe Aktiengesellschaft | 171.37M |
| Novabase S.G.P.S. | 130.35M |
| EUWAX Aktiengesellschaft | 41.42M |
| STINAG Stuttgart Invest AG | 28.92M |